Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-4-19
pubmed:abstractText
An elevated count of blood neutrophils and monocytes recently was shown independently to predict short survival in patients with stage IV melanoma undergoing interleukin-2-based immunotherapy. In this study, we aimed to validate this finding in a large cohort of stage IV melanoma patients.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1562-9
pubmed:dateRevised
2007-12-3
pubmed:meshHeading
pubmed-meshheading:17443000-Adult, pubmed-meshheading:17443000-Aged, pubmed-meshheading:17443000-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17443000-Disease-Free Survival, pubmed-meshheading:17443000-Dose-Response Relationship, Drug, pubmed-meshheading:17443000-Drug Administration Schedule, pubmed-meshheading:17443000-Female, pubmed-meshheading:17443000-Humans, pubmed-meshheading:17443000-Leukocyte Count, pubmed-meshheading:17443000-Male, pubmed-meshheading:17443000-Maximum Tolerated Dose, pubmed-meshheading:17443000-Melanoma, pubmed-meshheading:17443000-Middle Aged, pubmed-meshheading:17443000-Neoplasm Staging, pubmed-meshheading:17443000-Neutrophils, pubmed-meshheading:17443000-Predictive Value of Tests, pubmed-meshheading:17443000-Probability, pubmed-meshheading:17443000-Prognosis, pubmed-meshheading:17443000-Proportional Hazards Models, pubmed-meshheading:17443000-Reference Values, pubmed-meshheading:17443000-Risk Factors, pubmed-meshheading:17443000-Sensitivity and Specificity, pubmed-meshheading:17443000-Skin Neoplasms, pubmed-meshheading:17443000-Survival Analysis, pubmed-meshheading:17443000-Tumor Markers, Biological, pubmed-meshheading:17443000-United States
pubmed:year
2007
pubmed:articleTitle
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
pubmed:affiliation
Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark. hesch@as.aaa.dk
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural